Gemvax Overview
- Founded
-
2001
- Status
-
Acquired/Merged
- Latest Deal Type
-
M&A
- Financing Rounds
-
2
Gemvax General Information
Description
Developer and manufacturer of pharmaceutical products. The company is focused on the development of peptide vaccines, which are innovative immunotherapeutic anti-cancer drugs.
Contact Information
Website
www.gemvax.com
Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Office
- Teknologisenteret
- Kjølnes Ring
- 3918 Porsgrunn
- Norway
Gemvax Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Gemvax Patents
Gemvax Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| AU-2002307645-A1 | Polypeptides derived from human telomerase reverse transcriptase | Inactive | 21-May-2001 | ||
| AU-2002248083-A1 | A method for transfection of rna using electrical pulses | Inactive | 04-May-2001 | ||
| CA-2446036-A1 | A method for transfection of rna using electrical pulses | Inactive | 04-May-2001 | 000000000 | |
| EP-1390512-A1 | A method for transfection of rna using electrical pulses | Inactive | 04-May-2001 | 000000000 | |
| GB-0111015-D0 | Genetic material | Inactive | 04-May-2001 | C12N15/87 |
Gemvax Former Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Gemvax Subsidiaries (1)
| Company Name | Industry | Location | Founded |
|---|---|---|---|
| 00000000 | Construction and Engineering | Daejeon, South Korea | 0000 |